CXCR4‐targeting nanobodies differentially inhibit CXCR4 function and HIV entry
Sign Up to like & getrecommendations! Published in 2018 at "Biochemical Pharmacology"
DOI: 10.1016/j.bcp.2018.10.015
Abstract: &NA; The chemokine receptor CXCR4 and its ligand CXCL12 contribute to a variety of human diseases, such as cancer. CXCR4 is also a major co‐receptor facilitating HIV entry. Accordingly, CXCR4 is considered as an attractive… read more here.
Keywords: hiv entry; cxcr4 targeting; activity; targeting nanobodies ... See more keywords